Corticotropin-releasing hormone receptor type 1 and type 2 mediate differential effects on 15-hydroxy prostaglandin dehydrogenase expression in cultured human chorion trophoblasts

Endocrinology

Volumn 148, Issue 8, 2007, Pages 3645-3654

  Gao, Lu ^a   He, Ping ^a   Sha, Jinyan ^a   Liu, Chunmin ^a   Dai, Ling ^a   Hui, Ning ^a   Ni, Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANTALARMIN; ASTRESSIN; CORTICOTROPIN; CORTICOTROPIN [9 41]; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; UROCORTIN;

ARTICLE; CELL CULTURE; CHORION; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOMETRIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TROPHOBLAST;

CELLS, CULTURED; CHORION; CORTICOTROPIN-RELEASING HORMONE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HORMONE ANTAGONISTS; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; PEPTIDE FRAGMENTS; PREGNANCY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TROPHOBLASTS;

EID: 34547125803     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1212     Document Type: Article

References (50)

1. Novy MJ, Liggins GC 1980 Role of prostaglandins, prostacyclin, and thromboxanes in the physiologic control of the uterus and parturition. Semin Perinatol 4:45-65
2. Mitchell MD 1984 The mechanism(s) of human parturition. J Dev Physiol 6:107-118
3. Challis J, Matthews SG, Gibb W, Lye SJ 2000 Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21:1-37
4. Olson DM 2003 The role of prostaglandins in the initiation of parturition. Best Pract Res Clin Obstet Gynaecol 17:717-730
5. Myatt L, Lye SJ 2004 Expression, localization and function of prostaglandin receptors in myometrium. Prostaglandins Leukot Essent Fatty Acids 70:137-148
6. Carter AM 1998 Few autacoids have a proven role in the physiological regulation of fetal placental blood flow. Trophoblast Research 11:279-297
7. Mitchell M, Trautman M 1993 Molecular mechanisms regulating prostaglandin action. Mol Cell Endocrinol 93:C7-C10
8. Okita RT, Okita JR 1996 Prostaglandin-metabolizing enzymes during pregnancy: characterization of NAD-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omegahydroxylase. Crit Rev Biochem Mol Biol 31:101-126
9. Hirst J, Teixeria F, Zakar T, Olson D 1995 Prostaglandin H synthase-2 expression increases in human gestational tissues with spontaneous labour onset. Reprod Fertil Dev 7:633-637
10. Cheung P, Walton J, Tai HH, Riley SC, Challis J 1992 Localization of 15-hydroxyprostaglandin dehydrogenase in human fetal membranes, decidua, and placenta during pregnancy. Gynecol Obstet Invest 33:142-146
11. Johnson R, Mitchell C, Clifton V, Zakar T 2004 Regulation of 15-hydroxyprostaglandin dehydrogenase (PGDH) gene activity, messenger ribonucleic acid processing, and protein abundance in the human chorion in late gestation and labor. J Clin Endocrinol Metab 89:5639-5648
12. Van Meir CA, Sangha RK, Walton JC, Matthews SG, Keirse MJNC, Challis JR 1996 Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection. Placenta 17:291-297
13. Van Meir CA, Matthews SG, Keirse MJNC, Ramirez MM, Bocking A, Challis JR 1997 15-Hydroxyprostaglandin dehydrogenase: implications in preterm labor with and without ascending infection. J Clin Endocrinol Metab 82:969-976
14. McLean M, Bistis A, Davies JJ, Woods R, Lowry PJ, Smith R 1995 A placental clock controlling the length of human pregnancy. Nat Med 1:460-463
15. Goland RS, Wardlaw SL, Stark RI, Brown Jr LS, Frantz AG 1986 High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 63:1199-1203
16. Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami D, Go M, Shimizu Y, Hanew K, Yoshinaga K 1987 Immunoreactive corticotropin- releasing hormone in human plasma during pregnancy, labor and delivery. J Clin Endocrinol Metab 64:224-229
17. Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA 1998 Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 179:1079-1085
18. Riley SC, Challis JRG 1991 Corticotorphin-releasing hormone production by the placenta and fetal membranes. Placenta 12:105-119
19. Sehringer B, Zahradnik HP, Simon M, Ziegler R, Noethling C, Schaefer WR 2004 mRNA expression profiles for corticotrophin-releasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by real-time quantitative RT-PCR. J Mol Endocrinol 32:339-348
20. Riley SC, Walton JC, Herilick JM, Challis JR 1991 The localization and distribution of corticotrophin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 72:1001-1007
21. Gu Q, Clifton VL, Schwartz J, Madsen G, Sha J, Smith R 2001 Characterization of urocortin in human pregnancy. Chin Med J (Engl) 114:618-622
22. Petraglia F, Florio P, Gallo R, Simoncini T, Saviozzi M, DiBlasio AM, Vaughan J, Vale W 1996 Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 81:3807-3810
23. Imperatore A, Florio P, Torres PB, Torricelli M, Galleri L, Toti P, Occhini R, Picciolini E, Vale W, Petraglia F 2006 Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. Am J Obstet Gynecol 195:288-295
24. Richard D, Lin Q, Timofeeva E 2002 The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur J Pharmacol 440:189-197
25. Grammatopoulos DK, Chrousos GP 2002 Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13:436-444
26. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET 2001 Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15:1678-1693
27. Florio P, Franchini A, Reis FM, Pezzani I, Ottanviani E, Petraglia F 2000 Human placenta, chorion, amnion and decidua express different variants of corticotrophin-releasing factor receptor messenger RNA. Placenta 21:32-37
28. Wetzka B, Sehringer B, Schafer WR, Biller S, Hor C, Benedek E, Deppert WR, Zahradnik HP 2003 Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term. Exp Clin Endocrinol Diabetes 111:154-161
29. McKeown KJ, Challis JR 2003 Regulation of 15-hydroxy prostaglandin dehydrogenase by corticotrophin-releasing hormone through a calcium-dependent pathway in human chorion trophoblast cells. J Clin Endocrinol Metab 88:1737-1741
30. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF 1986 Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118:1567-1582
31. Li W, Gao L, Wang Y, Duan T, Myatt L, Sun K 2006 Enhancement of cortisol-induced 11β-hydroxysteroid dehydrogenase type 1 expression by interleukin 1 in cultured human chorionic trophoblast cells. Endocrinology 147:2490-2495
32. Karteris E, Papadopoulou N, Grammatopoulos DK, Hillhouse EW 2004 Expression and signaling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. J Mol Endocrinol 32:21-32
33. Pisarchik A, Slominski AT 2001 Alternative splicing of CRHR1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15:2754-2756
34. -ΔΔC(T) method. Methods 25:402-408
35. Ni X, Chan EC, Fitter JT, Smith R 1997 Nitric oxide inhibits corticotrophin releasing hormone exocytosis but not biosynthesis by cultured human trophoblasts. J Clin Endocrinol Metab 82:4171-4175
36. Ross PC, Kostas CM, Ramabhadran TV 1994 A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem Biophys Res Commun 205:1836-1842
37. Chen R, Lewis KA, Perrin MH, Vale WW 1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971
38. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, De Souza EB 1996 Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72-77
39. Valdenaire O, Giller T, Breu V, Gottowik J, Kilpatrick G 1997 A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim Biophys Acta 1352:129-132
40. Kostich WA, Chen A, Sperle K, Largent BL 1998 Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2γ receptor. Mol Endocrinol 12:1077-1085
41. Sirianni R, Mayhew BA, Carr BR, Parker CR, Rainey WE 2005 Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J Clin Endocrinol Metab 90:5393-5400
42. Hillhouse EW, Grammatopoulos DK 2006 The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 27:260-286
43. Karteris E, Goumenou A, Koumantakis E, Hillhouse EW, Grammatopoulos DK 2003 Reduced expression of corticotropin-releasing hormone receptor type-1α in human preeclamptic and growth-restricted placentas. J Clin Endocrinol Metab 88:363-370
44. Wille S, Sydow S, Palchaudhuri MR, Spiess J, Dautzenberg FM 1999 Identification of amino acids in the N-terminal domain of corticotropin- releasing factor receptor 1 that are important determinants of high-affinity ligand binding. J Neurochem 72:388-395
45. Pisarchik A, Slominski A 2004 Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur J Biochem 271:2821-2830
46. Nakla S, Skinner K, Mitchell B, Challis J 1986 Changes in prostaglandin transfer across human fetal membranes obtained after spontaneous labor. Am J Obstet Gynecol 155:1337-1341
47. Sullivan M, Roseblade C, Elder M 1991 Metabolism of prostaglandin E2 on the fetal and maternal sides of intact fetal membranes. Acta Obstet Gynecol Scand 70:425-427
48. Clifton VL, Qing G, Murphy VE, Schwartz J, Madsen G, Smith R 2000 Localization and characterization of urocortin during human pregnancy. Placenta 21:782-788
49. Glynn BP, Wolton A, Rodriguez-Linares B, Phaneuf S, Linton EA 1998 Urocortin in pregnancy. Am J Obstet Gynecol 179:533-539
50. Florio P, Cobellis L, Woodman J, Severi FM, Linton EA, Petraglia F 2002 Levels of maternal plasma corticotropin-releasing factor and urocortin during labor. J Soc Gynecol Investig 9:233-237